IVF with gender selection in Malaysia costs from $7,200 to $10,500. The total price depends on the number of embryos tested and medication needs. Major hubs include Kuala Lumpur, Selangor, and Johor Bahru. In the US, patients typically spend $30,000 for similar services. Choosing Malaysia offers savings of approximately 70%. Standard bundles usually include egg retrieval, fertilization, and chromosomal screening.
Bookimed Expert Insight: High success rates at Alpha Fertility Centre justify the investment. They achieved Malaysia's first successful fertilization in 1986. Specialist Haris Hamzan pioneered IVF in the region. Patients benefit from on-site laboratories and high-comfort private wards. We recommend clinics using PGT-A for the most accurate chromosomal screening. Malaysian centers often provide flexible payment plans for international patients.
| Malaysia | Türkei | Österreich | |
| IVF mit Geschlechtsauswahl | von $7,200 | von $6,500 | von $12,000 |
Bookimed erhebt keine zusätzlichen Gebühren für IVF mit Geschlechtsauswahl-Preise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihr IVF mit Geschlechtsauswahl bei Ihrer Ankunft.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards für IVF mit Geschlechtsauswahl einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu versorgen.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer IVF mit Geschlechtsauswahl-Reise nie allein.
Tag 1
Tag 2
Tag 3-4
Tag 5
Tag 6
Tag 7
Woche 1-2
Woche 3
Woche 4
Woche 6
Bitte beachten Sie, dass jeder Fall individuell ist und der bereitgestellte Zeitplan ein ungefährer Richtwert ist.
Dr. Colin Lee Soon Soo ist auf Fertilität und laparoskopische Chirurgie spezialisiert und bringt im Alpha Fertility Centre ausgewiesene Expertise in der IVF mit Geschlechtsauswahl ein.
Pionier der IVF in Malaysia – Dr. Hamzan führte die In-vitro-Fertilisation 1986 im Land ein und ist seither ein führender Fertilitätsspezialist.
Dr. Leong Wai Yew ist ein engagierter Kinderwunschspezialist am Alpha Fertility Centre mit Schwerpunkt auf personalisierten IVF-Behandlungen.
Dr. Tan Chong Seong bietet spezialisiertes Fachwissen in der Reproduktionsmedizin am Alpha Fertility Centre an.
IVF mit Geschlechtsselektion ist eine Fruchtbarkeitsbehandlung, die es Eltern ermöglicht, das Geschlecht ihres Kindes mit Hilfe der assistierten Reproduktionstechnologie zu wählen.
Elective gender selection for family balancing is generally prohibited in Malaysia under Malaysian Medical Council guidelines. Medical practitioners may only utilize Preimplantation Genetic Testing to prevent severe sex-linked genetic disorders. While some facilities navigate regulatory gaps, reputable clinics strictly follow these medical necessity protocols.
Bookimed Expert Insight: While Malaysia is a top 10 global destination for fertility, clinics like Alpha Fertility Centre emphasize medical-grade PGT. Our data shows patients seeking elective options often pivot to the USA or UAE instead. Language barriers are non-existent here, as specialists like Dr. Haris Hamzan are UK-trained.
Patient Consensus: Patients note that elective selection is not openly advertised due to ethical sensitivities. Most advice suggests inquiring directly about PGT-A policies during an initial consultation to confirm specific clinic boundaries.
Gender selection during IVF is greater than 99.9% accurate when using Preimplantation Genetic Testing (PGT). This laboratory process identifies XX or XY chromosomes in embryos before transfer. While the identification is nearly perfect, it does not guarantee a successful pregnancy or the availability of your preferred sex.
Bookimed Expert Insight: Malaysia has become a top 10 global destination, serving over 1,000 requests through our platform. Clinics like Alpha Fertility Centre in Selangor utilize advanced embryo biopsy techniques. While the lab accuracy is near 100%, the real challenge is producing enough viable embryos. Some patients choose Malaysia because specialists there have pioneered these technologies since the late 1980s.
Patient Consensus: Patients emphasize that while the genetic test result is certain, the main emotional hurdle is achieving a successful pregnancy. Most recommend confirming the specific use of PGT/PGD biopsy over less reliable traditional methods like sperm sorting.
Laboratory selection of an embryo's sex involves Preimplantation Genetic Testing for Aneuploidy (PGT-A) on day 5 or 6 blastocysts. Embryologists use intracytoplasmic sperm injection (ICSI) for fertilization. They then biopsy cells from the trophectoderm layer to identify XX (female) or XY (male) chromosomes with nearly 100% accuracy.
Bookimed Expert Insight: Genetic screening creates a logistical bottleneck where timing is everything. Data from Alpha Fertility Centre shows they utilize in-house laboratories to minimize these delays. Malaysian clinics often batch samples for next-generation sequencing. This allows families to plan transfers more predictably than clinics relying on third-party labs.
Patient Consensus: Success depends heavily on embryos reaching the blastocyst stage. Patients emphasize that chromosome testing helps select the desired sex while also screening for genetic health.
Alpha IVF, Sunway Fertility, and TMC Fertility are leading Malaysian centers providing advanced PGT-A and PGT-M. These clinics utilize next-generation sequencing to detect chromosomal abnormalities and specific genetic disorders. Facilities in Selangor and Kuala Lumpur often feature in-house laboratories to streamline embryo biopsy results.
Bookimed Expert Insight: Alpha Fertility Centre stands out for its deep clinical experience, as its team includes the specialist who introduced IVF to Malaysia in 1986. While many centers offer genetic testing, Alpha’s ability to combine HLA typing with PGT-M on one platform is a specific technical advantage for families seeking genetic compatibility alongside disease screening.
Patient Consensus: Patients emphasize verifying if a clinic performs embryo biopsies in-house or ships samples to external labs, as this affects both the turnaround time and total costs. Many recommend specifically asking about trophectoderm biopsy techniques to ensure the highest safety for the embryos.